Correspondence
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure
-
* Corresponding author: Sebastiaan J van Hal vanhal@gotalk.net.au
1 Centre for Infectious Diseases and Microbiology, ICPMR Westmead Hospital, University of Sydney, Westmead 2145, NSW, Australia
2 Retroviral Genetics Division, Centre for Virus Research, Westmead Millennium Institute, Westmead 2145, NSW, Australia
3 Universiti Sains Malaysia, Department of Medical Microbiology and Parasitology, Kota Bharu, Kelantan, Malaysia
Retrovirology 2009, 6:12 doi:10.1186/1742-4690-6-12
Published: 9 February 2009Abstract
In a recent summary of integrase sequences, primary integrase inhibitor mutations were rare. In a review of integrase inhibitor-naïve Australian HIV-1 sequences, primary mutations were not identified, although the accessory mutation G140S was detected. A link with previous antiretroviral therapy, intra-subtype B divergence across the integrase gene and transmission of integrase polymorphisms were also noted. Based on these findings, we would recommend ongoing surveillance of integrase mutations, and integrase region sequencing for patients prior to commencement of integrase inhibitors.